Journal of Clinical Endocrinology & Metabolism, Vol 75, 1487-1490, Copyright © 1992 by Endocrine Society

ARTICLES

Renal clearance, metabolic clearance rate, and half-life of human growth hormone in young and aged subjects

M Sohmiya and Y Kato
Department of Medicine, Shimane Medical University, Izumo, Japan.

We studied the renal clearance, MCR, and half-life of the synthetic 22K form of human GH [recombinant hGH (rhGH)] in seven healthy young and five aged men by means of the constant iv infusion technique. rhGH was infused at a rate of 2 micrograms/kg.2 mL/h for 150 min, after which its disappearance was followed for 50 min. Changes in GH levels in plasma and urine were measured by a highly sensitive enzyme immunoassay. The mean (+/- SD) renal clearance of GH was significantly greater in the aged group than in the young group (14.3 +/- 2.5 vs. 4.2 +/- 1.0 microL/min; P < 0.05). The mean MCR was greater in the young group than in the aged group (187.1 +/- 43.7 vs. 120.5 +/- 39.5 mL/min; P < 0.05), but the MCR adjusted for body weight was not different between the two groups (2.9 +/- 0.6 vs. 2.3 +/- 0.8 mL/min.kg). No difference was noted in the half-life of GH between the two groups (13.8 +/- 0.9 vs. 14.2 +/- 0.4 min). These findings indicate that GH reabsorption from the renal tubule may be impaired in elderly subjects, but the disappearance rate of GH is not influenced by age.

This article has been cited by other articles:

				M. Sohmiya, I. Kanazawa, and Y. Kato Effect of recombinant human GH on circulating granulocyte colony-stimulating factor and neutrophils in patients with adult GH deficiency Eur. J. Endocrinol., February 1, 2005; 152(2): 211 - 215. [Abstract] [Full Text] [PDF]

				M. Sohmiya and Y. Kato Human growth hormone and insulin-like growth factor-I inhibit erythropoietin secretion from the kidneys of adult rats J. Endocrinol., January 1, 2005; 184(1): 199 - 207. [Abstract] [Full Text] [PDF]

				T. K. Hansen, C. H. Gravholt, H. Orskov, M. H. Rasmussen, J. S. Christiansen, and J. O. L. Jorgensen Dose Dependency of the Pharmacokinetics and Acute Lipolytic Actions of Growth Hormone J. Clin. Endocrinol. Metab., October 1, 2002; 87(10): 4691 - 4698. [Abstract] [Full Text] [PDF]

				T. K. Hansen, J. O. L. Jorgensen, and J. S. Christiansen Body Composition and Circulating Levels of Insulin, Insulin-Like Growth Factor-Binding Protein-1 and Growth Hormone (GH)-Binding Protein Affect the Pharmacokinetics of GH in Adults Independently of Age J. Clin. Endocrinol. Metab., May 1, 2002; 87(5): 2185 - 2193. [Abstract] [Full Text] [PDF]

				N. Shah, J. Aloi, W. S. Evans, and J. D. Veldhuis Time Mode of Growth Hormone (GH) Entry into the Bloodstream and Steady-State Plasma GH Concentrations, Rather Than Sex, Estradiol, or Menstrual Cycle Stage, Primarily Determine the GH Elimination Rate in Healthy Young Women and Men J. Clin. Endocrinol. Metab., August 1, 1999; 84(8): 2862 - 2869. [Abstract] [Full Text]